Arriva Pharmaceuticals Adds $6M
Alameda- and Amsterdam-based Arriva Pharmaceuticals said Thursday that the firm has raised $6M in a funding round. The funding came from Nordic Biotech II K/S and MPM BioVentures. The round brings the company's total raised to $81M. Arriva Pharmaceuticals is developing anti-inflammatory treatments for respiratory disease.
posted on Friday, February 29, 2008 (Link to more information)
Related companies:
Arriva Pharmaceuticals
Related stories:
> APT Pharmaceuticals Adds On $22M
> MAP Pharmaceuticals Sets IPO Pricing
> Skyline Ventures Adds Director, Opens Boston Office
> Aldea Pharmaceuticals Takes $24M
> Alexza Pharmaceuticals Acquired By Ferrer
silicontap.com Home